<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bioph</journal-id><journal-title-group><journal-title xml:lang="ru">Biomedical Photonics</journal-title><trans-title-group xml:lang="en"><trans-title>Biomedical Photonics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2413-9432</issn><publisher><publisher-name>Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24931/2413-9432-2023-12-2-4-10</article-id><article-id custom-type="elpub" pub-id-type="custom">bioph-589</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Паллиативное хирургическое лечение с применением фотодинамической терапии больных со злокачественными новообразованиями желчевыводящей системы, осложненными обструктивной желтухой</article-title><trans-title-group xml:lang="en"><trans-title>Palliative surgical treatment using photodynamic therapy for biliary cancer complicated by obstructive jaundice</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цеймах</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Tseimakh</surname><given-names>A. Е.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барнаул</p><p> </p></bio><bio xml:lang="en"><p>Barnaul</p></bio><email xlink:type="simple">alevtsei@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мищенко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitshenko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куртуков</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurtukov</surname><given-names>V. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шойхет</surname><given-names>Я. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shoykhet</surname><given-names>Ia. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барнаул</p></bio><bio xml:lang="en"><p>Barnaul</p><p> </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Алтайский государственный медицинский университет<country>Россия</country></aff><aff xml:lang="en">Altai State Medical University<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Городская больница №5<country>Россия</country></aff><aff xml:lang="en">State hospital №5<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>08</month><year>2023</year></pub-date><volume>12</volume><issue>2</issue><fpage>4</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Цеймах А.Е., Мищенко А.Н., Куртуков В.А., Шойхет Я.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Цеймах А.Е., Мищенко А.Н., Куртуков В.А., Шойхет Я.Н.</copyright-holder><copyright-holder xml:lang="en">Tseimakh A.Е., Mitshenko A.N., Kurtukov V.А., Shoykhet I.N.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pdt-journal.com/jour/article/view/589">https://www.pdt-journal.com/jour/article/view/589</self-uri><abstract><p>В работе представлены результаты исследования выживаемости, маркеров гемостаза, протеолиза и опухолевой инвазии после комплексного паллиативного лечения больных с гистологически верифицированными злокачественными новообразованиями желчевыводящих протоков, осложненными обструктивной желтухой в двух сопоставимых группах больных. Целью исследования было оценить эффективность паллиативного хирургического лечения с применением фотодинамической терапии (ФДТ) у больных злокачественными новообразованиями желчевыводящей системы, осложненными обструктивной желтухой. У 10 пациентов основной группы проводилось паллиативное хирургическое лечение с применением ФДТ, у 20 пациентов группы сравнения проводилось паллиативное хирургическое лечение без применения ФДТ. У пациентов основной группы наблюдалось статистически значимое увеличение продолжительности жизни по сравнению с группой сравнения на 104 дня (р=0,033). При этом выявлено статистически значимое влияние маркера опухолевой инвазии – фактора некроза опухоли α на выживаемость (р=0,012) и уменьшение его уровня после ФДТ с 43,53±33,99 пг/мл до 28,33±26,12 пг/мл (p = 0,041). Таким образом, паллиативное лечение с применением ФДТ злокачественных новообразований желчевыводящих протоков, осложненных обструктивной желтухой, позволяет увеличить выживаемость пациентов за счет уменьшения опухолевой инвазии.</p></abstract><trans-abstract xml:lang="en"><p>The article presents the results of a study of survival, markers of hemostasis, proteolysis, and tumor invasion after complex palliative treatment of patients with histologically verified malignant tumors of the bile ducts complicated by obstructive jaundice in two comparable groups of patients. The aim of the study was to evaluate the effectiveness of palliative surgical treatment using photodynamic therapy in patients with malignant tumors of the biliary system complicated by obstructive jaundice. In 10 patients of the main group, palliative surgical treatment was performed using photodynamic therapy; in 20 patients of the comparison group, palliative surgical treatment was performed without photodynamic therapy. In patients of the main group, a statistically significant increase in life expectancy by 104 days (p=0.033) was observed compared to the comparison group. At the same time, a statistically significant effect of tumor necrosis factor α, a marker of tumor invasion, on survival (p = 0.012) and a decrease in its level after photodynamic therapy by 15 pg/ml (p=0.041) was revealed. Thus, palliative treatment using photodynamic therapy of malignant tumors of the bile ducts, complicated by obstructive jaundice, can increase the survival rate of patients by reducing tumor invasion.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>злокачественные новообразования желчевыводящей системы</kwd><kwd>фотодинамическая терапия</kwd><kwd>выживаемость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>biliary cancer</kwd><kwd>photodynamic therapy</kwd><kwd>surviva</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Состояние онкологической помощи населению России в 2020 году / под ред. А.Д. Каприна, В. В. Старинского, Г. В. Петровой – М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России. – 2021. – С. 239.</mixed-citation><mixed-citation xml:lang="en">Status of oncological care for the population of Russia in 2020 / ed. A.D. Kaprin, V.V. Starinskogo, G.V. Petrova – M .: MSIOI named after. P.A. Herzen, branch of the FSBI «NMICR» of the Russian Ministry of Health, 2021, р. 239.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X. et al. Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update // Intractable Rare Dis Res. – 2022. – Vol. 11(4). – P. 161-172.</mixed-citation><mixed-citation xml:lang="en">Zhang X. et al. Comparison of current guidelines and consensus on the management of patients with cholangiocarcinoma: 2022 update. Intractable Rare Dis Res, 2022, vol. 11(4), рp. 161-172.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Общероссийский национальный союз «Ассоциация онкологов России». Рак желчевыводящей системы. Клинические рекомендации. – 2020. – С. 51. Ссылка активна на 23.03.2023. https://oncology-association.ru/wp-content/uploads/2020/09/biliarnyj_rak.pdf</mixed-citation><mixed-citation xml:lang="en">Russian Oncology Association. Biliary cancer. Clinical guidelines. 2020. 51 p. Accessed March 23, 2023 (In Russian) https://oncology-association.ru/wp-content/uploads/2020/09/biliarnyj_rak.pdf</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zеrеm Е., Imširоvić B., Kunоsić S. еt аl. Pеrcutаnеоus biliаry drаinаgе fоr оbstructivе jаundicе in pаtiеnts with inоpеrаblе, mаlignаnt biliаry оbstructiоn // Clin Еxp Hеpаtоl. – 2022. – №8(1). – P. 70-77.</mixed-citation><mixed-citation xml:lang="en">Zеrеm Е., Imširоvić B., Kunоsić S. еt аl. Pеrcutаnеоus biliаry drаinаgе fоr оbstructivе jаundicе in pаtiеnts with inоpеrаblе, mаlignаnt biliаry оbstructiоn. Clin Еxp Hеpаtоl, 2022, vol. 8(1), pр. 70-77.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shаh R., Jоhn S. Chоlеstаtic Jаundicе // In: StаtPеаrls [Intеrnеt]. Trеаsurе Islаnd (FL): StаtPеаrls Publishing. – 2022. – PMID: 29489239.</mixed-citation><mixed-citation xml:lang="en">Shаh R., Jоhn S. Chоlеstаtic Jаundicе. In: StаtPеаrls [Intеrnеt]. Trеаsurе Islаnd (FL): StаtPеаrls Publishing, 2022, PMID: 29489239.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Цеймах А.Е., Лазарев А.Ф., Куртуков В.А. и соавт. Способ комплексного мини-инвазивного лечения механической желтухи, холангита, внутрипеченочных абсцессов опухолевого генеза с применением локальной и системной фотодинамической терапии. – Патент РФ №2704474. – 2019. [Tseimakh A.E et al. Method for complex mini-invasive treatment of obstructive jaundice, cholangitis, intrahepatic abscesses of tumor genesis using local and systemic photodynamic therapy. Patent RF, no. 2704474. – 2019. (In Russian)]</mixed-citation><mixed-citation xml:lang="en">Tseimakh A.E. et al. Method for complex mini-invasive treatment of obstructive jaundice, cholangitis, intrahepatic abscesses of tumor genesis using local and systemic photodynamic therapy. Patent RF, no. 2704474, 2019. (In Russian)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey // Annals of Surgery. – 2004. – Vol. 240(2). – P. 205-213.</mixed-citation><mixed-citation xml:lang="en">Dindo D., Demartines N., Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery, 2004, vol. 240(2), рp. 205-213.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Haider H., Chapman C.G., Siddiqui U.D. Maximizing survival in hilar cholangiocarcinoma patients using multi-modality therapy: photodynamic therapy (pdt) with stenting, chemotherapy, and radiation // Gastrointestinal Endoscopy. – 2020. – Vol. 91(6). – P. 1-5. doi: 10.1016/j.gie.2020.03.2226</mixed-citation><mixed-citation xml:lang="en">Haider H., Chapman C.G., Siddiqui U.D. Maximizing survival in hilar cholangiocarcinoma patients using multi-modality therapy: photodynamic therapy (pdt) with stenting, chemotherapy, and radiation. Gastrointestinal Endoscopy, 2020, vol. 91(6), рp. 1-5. doi: 10.1016/j.gie.2020.03.2226</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lu Y. et al. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis // Clinics and research in hepatology and gastroenterology. – 2015. – Vol. 39(6). – P. 718-724. doi: 10.1016/j.clinre.2014.10.015.</mixed-citation><mixed-citation xml:lang="en">Lu Y. et al. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis. Clinics and research in hepatology and gastroenterology, 2015, vol. 39(6), рp. 718-724. doi: 10.1016/j.clinre.2014.10.015.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Li Z. et al. Long-Term Results of ERCP- or PTCS-Directed Photodynamic Therapy for Unresectable Hilar Cholangiocarcinoma // Surg Endosc. – 2021. – Vol. 35(10). – P. 5655-64. doi: 10.1007/s00464-020-08095-1</mixed-citation><mixed-citation xml:lang="en">Li Z. et al. Long-Term Results of ERCP- or PTCS-Directed Photodynamic Therapy for Unresectable Hilar Cholangiocarcinoma. Surg Endosc, 2021, vol. 35(10), р p. 5655-5664. doi: 10.1007/s00464-020-08095-1</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Moole H. et al. Success of Photodynamic Therapy in Palliating Patients With Nonresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis // World J Gastroenterol. – 2017. – Vol. 23(7). – P. 1278-88. doi: 10.3748/wjg.v23.i7.1278</mixed-citation><mixed-citation xml:lang="en">Moole H. et al. Success of Photodynamic Therapy in Palliating Patients With Nonresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis. World J Gastroenterol, 2017, vol. 23(7), рp. 1278–88. doi: 10.3748/wjg.v23.i7.1278</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira S.P. et al. PHOTOSTENT-02: Porfimer Sodium Photodynamic Therapy Plus Stenting Versus Stenting Alone in Patients With Locally Advanced or Metastatic Biliary Tract Cancer // ESMO Open. – 2018. – Vol. 3(5). – Р. e000379. doi: 10.1136/esmoopen-2018-000379</mixed-citation><mixed-citation xml:lang="en">Pereira S.P. et al. PHOTOSTENT-02: Porfimer Sodium Photodynamic Therapy Plus Stenting Versus Stenting Alone in Patients With Locally Advanced or Metastatic Biliary Tract Cancer. ESMO Open, 2018, vol. 3(5), р. e000379. doi: 10.1136/esmoopen-2018-000379</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Maswikiti E.P., Chen H. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis // Photodiagnosis Photodyn Ther. – 2023. – Vol. 2 (41). – Р. 103318. doi: 10.1016/j.pdpdt.2023.103318.</mixed-citation><mixed-citation xml:lang="en">Maswikiti E.P., Chen H. Photodynamic therapy combined with systemic chemotherapy for unresectable extrahepatic cholangiocarcinoma: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther, 2023, vol 2 (41), р.103318. doi: 10.1016/j.pdpdt.2023.103318.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">А. П. Момот, Л. П. Цывкина, И. А. Тараненко Современные методы распознавания состояния тромботической готовности // Москва: Издательство «Знание-М». – 2022. – С. 146.</mixed-citation><mixed-citation xml:lang="en">Момот А.П., Цывкина Л.П., Тараненко И.А. Современные методы распознавания состояния тромботической готовности. Москва: Издательство «Знание-М», 2022, р. 146.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Streiff M.B. et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021 NCCN Clinical Practice Guidelines in Oncology // Journal of the National Comprehensive Cancer Network. – 2021. – Vol. 19(10). – P. 1181-1201.</mixed-citation><mixed-citation xml:lang="en">Streiff M.B. et al. Cancer-Associated Venous Thromboembolic Disease, Version 2.2021 NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 2021, vol. 19(10), pр. 1181-1201.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
